SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Julian Lindsay(Royal North Shore Hospital), Monica A. Slavin(The Royal Melbourne Hospital), Chris Arthur(Royal North Shore Hospital), Matthew Greenwood(The University of Sydney), William Stevenson(The University of Sydney), Ian Kerridge(The University of Sydney), Jad Othman(The University of Sydney), Steven A. Pergam(Seattle Cancer Care Alliance), David C. M. Kong, Annie Lai King Yip(Royal Prince Alfred Hospital), Yvonne Kong(The University of Sydney), Sebastiaan J. van Hal(The University of Sydney), Christian Bryant(Royal Prince Alfred Hospital), Catherine Liu(University of California, San Francisco), Keith Fay(Royal North Shore Hospital), Sharon C.-A. Chen(The University of Sydney), John Gibson(Royal Prince Alfred Hospital), Stephen Larsen(Royal Prince Alfred Hospital)
Cited by 15
Related Papers
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
|Clinical Infectious Diseases|2011|1.6k
<i>Staphylococcus aureus</i> with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods
|Antimicrobial Agents and Chemotherapy|2003|318